Literature DB >> 11839755

Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocation.

Fei Yu1, Russell L Finley, Avraham Raz, Hyeong-Reh Choi Kim.   

Abstract

Galectin-3 is a multifunctional oncogenic protein found in the nucleus and cytoplasm and also the extracellular milieu. Although recent studies demonstrated an anti-apoptotic activity of galectin-3, neither the functional site nor the mechanism of how galectin-3 regulates apoptosis is known. In this study, we examined the subcellular localization of galectin-3 during apoptosis and investigated its anti-apoptotic actions. We report that galectin-3 translocates to the perinuclear membrane following a variety of apoptotic stimuli. Confocal microscopy and biochemical analysis revealed that galectin-3 is enriched in the mitochondria and prevents mitochondrial damage and cytochrome c release. Using a yeast two-hybrid system, we screened for galectin-3-interacting proteins that regulate galectin-3 localization and anti-apoptotic activity. Synexin, a Ca(2+)- and phospholipid-binding protein, was one of the proteins identified. We confirmed direct interaction between galectin-3 and synexin by glutathione S-transferase pull-down assay in vitro. We showed that galectin-3 failed to translocate to the perinuclear membranes when expression of synexin was down-regulated using an oligodeoxyribonucleotide complementary to the synexin mRNA, suggesting a role for synexin in galectin-3 trafficking. Furthermore, synexin down-regulation abolished anti-apoptotic activity of galectin-3. Taken together, these results suggest that synexin mediates galectin-3 translocation to the perinuclear mitochondrial membranes, where it regulates mitochondrial integrity critical for apoptosis regulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11839755     DOI: 10.1074/jbc.M200154200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  108 in total

1.  Myenteric denervation downregulates galectin-1 and -3 expression in gastric carcinogenesis.

Authors:  Cássia F Estofolete; Sérgio Zucoloto; Sonia M Oliani; Ana Cláudia Polli-Lopes; Cristiane D Gil
Journal:  Dig Dis Sci       Date:  2010-12-29       Impact factor: 3.199

2.  Human galectin-3 immunoexpression in thyroid follicular adenomas with cell atypia.

Authors:  C Nucera; E Mazzon; B Caillou; M A Violi; M Moleti; C Priolo; G Sturniolo; D Puzzolo; V Cavallari; F Trimarchi; F Vermiglio
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

3.  Extracellular proteome of human hepatoma cell, HepG2 analyzed using two-dimensional liquid chromatography coupled with tandem mass spectrometry.

Authors:  Ryo Yamashita; Yuko Fujiwara; Kohei Ikari; Keiko Hamada; Asuka Otomo; Kazuki Yasuda; Mitsuhiko Noda; Yasushi Kaburagi
Journal:  Mol Cell Biochem       Date:  2006-11-16       Impact factor: 3.396

4.  Galectin-3 germline variant at position 191 enhances nuclear accumulation and activation of β-catenin in gastric cancer.

Authors:  Seok-Jun Kim; Ji-Young Shin; Teak-Chin Cheong; Il-Ju Choi; Yeon Su Lee; Seok Hee Park; Kyung-Hee Chun
Journal:  Clin Exp Metastasis       Date:  2011-07-13       Impact factor: 5.150

5.  Integration of 18O labeling and solution isoelectric focusing in a shotgun analysis of mitochondrial proteins.

Authors:  Jinshan Wang; Peter Gutierrez; Nathan Edwards; Catherine Fenselau
Journal:  J Proteome Res       Date:  2007-11-10       Impact factor: 4.466

6.  Galectin binding to Mgat5-modified N-glycans regulates fibronectin matrix remodeling in tumor cells.

Authors:  Annick Lagana; Jacky G Goetz; Pam Cheung; Avraham Raz; James W Dennis; Ivan R Nabi
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

7.  Galectin-3: a potential target for cancer prevention.

Authors:  Hafiz Ahmed; Prasun Guha; Engin Kaptan; Gargi Bandyopadhyaya
Journal:  Trends Carbohydr Res       Date:  2011

8.  Distinct effects on splicing of two monoclonal antibodies directed against the amino-terminal domain of galectin-3.

Authors:  Richard M Gray; Michael J Davis; Katherine M Ruby; Patricia G Voss; Ronald J Patterson; John L Wang
Journal:  Arch Biochem Biophys       Date:  2008-04-18       Impact factor: 4.013

9.  Galectin-1 functions as a Th2 cytokine that selectively induces Th1 apoptosis and promotes Th2 function.

Authors:  Claudia C Motran; Karen M Molinder; Scot D Liu; Françoise Poirier; M Carrie Miceli
Journal:  Eur J Immunol       Date:  2008-11       Impact factor: 5.532

10.  Galectin-1 induces nuclear translocation of endonuclease G in caspase- and cytochrome c-independent T cell death.

Authors:  H P Hahn; M Pang; J He; J D Hernandez; R-Y Yang; L Y Li; X Wang; F-T Liu; L G Baum
Journal:  Cell Death Differ       Date:  2004-12       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.